PH12018501246A1 - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds - Google Patents

Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Info

Publication number
PH12018501246A1
PH12018501246A1 PH12018501246A PH12018501246A PH12018501246A1 PH 12018501246 A1 PH12018501246 A1 PH 12018501246A1 PH 12018501246 A PH12018501246 A PH 12018501246A PH 12018501246 A PH12018501246 A PH 12018501246A PH 12018501246 A1 PH12018501246 A1 PH 12018501246A1
Authority
PH
Philippines
Prior art keywords
solid forms
phenylbenzo
isoquinolin
dihydro
substituted
Prior art date
Application number
PH12018501246A
Other languages
English (en)
Inventor
Craig Bates
David P Reed
Original Assignee
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arqule Inc filed Critical Arqule Inc
Publication of PH12018501246A1 publication Critical patent/PH12018501246A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH12018501246A 2015-12-17 2018-06-13 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds PH12018501246A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562268747P 2015-12-17 2015-12-17
PCT/US2016/067164 WO2017106642A1 (en) 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Publications (1)

Publication Number Publication Date
PH12018501246A1 true PH12018501246A1 (en) 2019-02-04

Family

ID=59057612

Family Applications (2)

Application Number Title Priority Date Filing Date
PH12018501246A PH12018501246A1 (en) 2015-12-17 2018-06-13 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
PH12020551465A PH12020551465A1 (en) 2015-12-17 2020-09-14 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH12020551465A PH12020551465A1 (en) 2015-12-17 2020-09-14 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Country Status (19)

Country Link
US (3) US9981921B2 (cg-RX-API-DMAC7.html)
EP (2) EP3390369B1 (cg-RX-API-DMAC7.html)
JP (2) JP2018537499A (cg-RX-API-DMAC7.html)
KR (1) KR20180086508A (cg-RX-API-DMAC7.html)
CN (1) CN108368061A (cg-RX-API-DMAC7.html)
AU (2) AU2016369523B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018012095A2 (cg-RX-API-DMAC7.html)
CA (1) CA3006081A1 (cg-RX-API-DMAC7.html)
EA (2) EA202091691A1 (cg-RX-API-DMAC7.html)
ES (1) ES2935818T3 (cg-RX-API-DMAC7.html)
HK (1) HK1256825A1 (cg-RX-API-DMAC7.html)
IL (1) IL259556B2 (cg-RX-API-DMAC7.html)
MX (2) MX385671B (cg-RX-API-DMAC7.html)
NZ (1) NZ742695A (cg-RX-API-DMAC7.html)
PH (2) PH12018501246A1 (cg-RX-API-DMAC7.html)
SA (1) SA518391805B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201804670PA (cg-RX-API-DMAC7.html)
TW (2) TWI796250B (cg-RX-API-DMAC7.html)
WO (1) WO2017106642A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106642A1 (en) * 2015-12-17 2017-06-22 Arqule, Inc. Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
MX2020012771A (es) 2015-12-17 2022-10-04 Arqule Inc Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma
JP7641247B2 (ja) 2022-03-02 2025-03-06 日立建機株式会社 機械の性能診断装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU5330698A (en) * 1996-12-23 1998-07-17 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
EP1790634A3 (en) * 2003-06-18 2007-06-13 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal form and processes for preparing it
CA2710051C (en) * 2006-12-29 2017-05-16 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
CN102325755B (zh) * 2008-12-30 2015-07-01 艾科尔公司 取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物
JP5808818B2 (ja) * 2010-11-25 2015-11-10 ラツィオファーム・ゲーエムベーハー アファチニブの新規塩及び多形形態
WO2012177852A1 (en) 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
US9802954B2 (en) * 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
WO2013044816A1 (en) * 2011-09-30 2013-04-04 Sunshine Lake Pharma Co., Ltd. Crystalline forms of azilsartan and preparation and uses thereof
WO2017106642A1 (en) * 2015-12-17 2017-06-22 Arqule, Inc. Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
MX2020012771A (es) * 2015-12-17 2022-10-04 Arqule Inc Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
US9847831B2 (en) 2016-04-08 2017-12-19 Ciena Corporation Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system

Also Published As

Publication number Publication date
AU2022201947A1 (en) 2022-04-14
US20200002293A1 (en) 2020-01-02
MX2018007414A (es) 2018-11-09
MX385671B (es) 2025-03-18
SG11201804670PA (en) 2018-07-30
CA3006081A1 (en) 2017-06-22
MX2021000432A (es) 2022-07-28
IL259556B2 (en) 2023-09-01
EP3390369A4 (en) 2019-08-14
TW202241854A (zh) 2022-11-01
BR112018012095A2 (pt) 2018-11-27
AU2016369523A1 (en) 2018-06-07
EA036295B1 (ru) 2020-10-22
EP4019499A1 (en) 2022-06-29
JP2022031797A (ja) 2022-02-22
IL259556A (en) 2018-07-31
EA201891430A1 (ru) 2018-11-30
TWI796250B (zh) 2023-03-11
NZ742695A (en) 2022-10-28
US10717710B2 (en) 2020-07-21
US9981921B2 (en) 2018-05-29
PH12020551465A1 (en) 2021-07-26
US10227311B2 (en) 2019-03-12
AU2022201947B2 (en) 2023-07-27
SA518391805B1 (ar) 2022-12-21
US20170174636A1 (en) 2017-06-22
MX394320B (es) 2025-03-24
JP2018537499A (ja) 2018-12-20
TWI771280B (zh) 2022-07-21
TW201736352A (zh) 2017-10-16
EP3390369B1 (en) 2022-11-02
EP3390369A1 (en) 2018-10-24
WO2017106642A1 (en) 2017-06-22
HK1256825A1 (zh) 2019-10-04
EA202091691A1 (ru) 2021-01-29
IL259556B1 (en) 2023-05-01
AU2016369523B2 (en) 2021-12-23
US20180258055A1 (en) 2018-09-13
KR20180086508A (ko) 2018-07-31
CN108368061A (zh) 2018-08-03
ES2935818T3 (es) 2023-03-10

Similar Documents

Publication Publication Date Title
PH12017502090A1 (en) Heterocyclic amides as kinase inhibitors
EP3672973A4 (en) HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF, AND METHODS OF USING THEREOF
WO2017108723A3 (en) PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
PH12020551465A1 (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
MX2021015102A (es) Inhibidores del receptor del factor estimulante de colonias 1 (csf-1r).
SG11202011513RA (en) Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
PH12016502523A1 (en) Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
PH12019550235A1 (en) Kinase inhibitors and uses thereof
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
PH12018500736A1 (en) Methods for treating multiple sclerosis using pyrimidine and pyridine compounds with btk inhibitory activity
MX2020011478A (es) Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos.
IL271399A (en) Methods for the preparation of heterocyclic 3,1-benzodioxole compounds
EP3448852A4 (en) NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF TYROSINE KINASE BCR-ABL
GEP20186841B (en) Stabilized crystal of tipiracil hydrochloride, and crystallization method for same
IL271974A (en) New intermediates useful for the synthesis of aminopyrimidine derivatives, a process for their preparation and a process for preparing aminopyrimidine derivatives using them
DK3412673T3 (da) Fremgangsmåde til fremstilling af pyrrolo[3,2-D]pyrimidin-forbindelse og mellemprodukter deraf
MX2019011116A (es) Inhibidores de la tirosina quinasa de bruton.
TW201613934A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
MX2015013414A (es) N-(2-ciano heterociclil)pirazolo piridonas como inhibidores de janus quinasa.
MX2023001805A (es) Formas solidas de 2-(5-(4-(2-morfolinoetoxi)fenil)piridin-2-il)-n- bencilacetamida.
SG10201908248PA (en) Processes for preparing fluoroketolides
GEP20207127B (en) 2-homopiperazine-1-yl-4h-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides
HK40032669A (en) Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate
HK40037119A (en) Pyrimidine compounds useful as tyrosine kinase inhibitors
EP3727387A4 (en) PYRIMIDINE COMPOUNDS USEFUL AS TYROSINE KINASE INHIBITORS